![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » JUBILANT ORGANOSYS Q4 NET UP 31.7%
JUBILANT ORGANOSYS Q4 NET UP 31.7%
Jubilant Organosys Ltd on Tuesday announced an increase
of 31.7 per cent in net profit at Rs 47.4 crore for the fourth quarter 2005-06
as compared to Rs 36 crore for the same period in 2004-05. Net sales grew 18.9
per cent to Rs 369 crore for the fourth quarter 2005-06 as against Rs 311 crore
in the year-ago period.
Sify
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct